Current perspectives on psychedelic treatments in Europe.
Lancet Reg Health Eur November 20, 2025 Santiago Madero, Oscar Soto-Angona, Genís Ona et al. 9 citations
Psychedelic-assisted therapy in Europe is gaining momentum through recent initiatives in Switzerland, Germany, and the Czech Republic, though access remains limited. The authors argue for an integrative framework that considers neurobiological mechanisms, subjective experience, and contextual factors, emphasizing how effects involving neuroplasticity and critical periods may interact with psychotherapeutic processes. Context and psychological support are highlighted as crucial for shaping outcomes. Regulatory fragmentation and methodological complexities hinder progress, but publicly funded trials such as EPIsoDE and PsyPal offer promising examples of ethical and effective approaches. The future of psychedelic therapy lies in embracing its complexity.